HCPA’s Scientific & Regulatory Affairs team supports each of HCPA’s seven Product Divisions to ensure that member companies are aware of ongoing and emerging scientific and regulatory issues in order to maximize the opportunities presented by the ever-changing regulatory landscape.
The Scientific & Regulatory Affairs team works closely with members to identify opportunities and concerns and develop strategies related to these issues to advance the industry’s interests. Members also rely on the Scientific & Regulatory Affairs team to provide timely updates on pending scientific or regulatory issues that may directly or indirectly impact member companies’ products.
Most recently, the Scientific & Regulatory Affairs team, working with HCPA’s Antimicrobial Products Division, has played a critical role in fighting the coronavirus pandemic, especially by addressing supply chain concerns to ensure that disinfectants remain available for consumers and workers. For example, we provided input to the EPA on List N and made recommendations about ingredients that should be added to the EPA’s Commodity Inert Ingredients List.
In addition to issues related to COVID-19, we are also:
Providing input to CARB and other state agencies on proposed VOC regulations
Advocating for regulatory relief for Pet Spot-On Products
Reducing the regulatory burden for Minimum Risk Pesticides (25(b) products)
Implementing TSCA reform and risk evaluation for the first 10 chemicals
Preparing for the OSHA-HAZCOM Standard Update
Petitioning the Department of Transportation to standardize the definition of an aerosol
Providing information on tariffs and implementation of the Lacey Act by the USDA
Aiding in ingredient communication efforts through the HCPA Ingredient Dictionary
Working with states to incorporate aerosol cans in universal waste programs
Informing on chemicals of concern, such as 1,4-dioxane, chlorinated solvents, HFCs, and quats
Providing input on microplastics/plastics and other end-of-life concerns
Additionally, the Scientific & Regulatory Affairs team has productive working relationships with federal and state agencies, including the Environmental Protection Agency (EPA), Consumer Product Safety Commission (CPSC), and California Air Resources Board (CARB). Members are often invited to participate in meetings with senior-level officials from each of these agencies to discuss the industry’s perspective on scientific and regulatory issues. Additionally, Scientific & Regulatory Affairs staff provide technical and stakeholder input to the EPA by serving on advisory committees, including the Science Advisory Committee on Chemicals (SACC) and the Pesticide Program Dialogue Committee (PPDC). We also regularly coordinate with other U.S. and international trade associations to align on scientific and regulatory issues.
In order to help our members expand and enhance their knowledge of important issues, HCPA regularly hosts meetings, workshops, and webinars about priority issues, featuring insight from industry experts.
HCPA’s Scientific & Regulatory Affairs team supports each of HCPA’s seven Product Divisions to ensure that member companies are aware of ongoing and emerging scientific and regulatory issues in order to maximize the opportunities presented by the ever-changing regulatory landscape.
The Scientific & Regulatory Affairs team works closely with members to identify opportunities and concerns and develop strategies related to these issues to advance the industry’s interests. Members also rely on the Scientific & Regulatory Affairs team to provide timely updates on pending scientific or regulatory issues that may directly or indirectly impact member companies’ products.
Most recently, the Scientific & Regulatory Affairs team, working with HCPA’s Antimicrobial Products Division, has played a critical role in fighting the coronavirus pandemic, especially by addressing supply chain concerns to ensure that disinfectants remain available for consumers and workers. For example, we provided input to the EPA on List N and made recommendations about ingredients that should be added to the EPA’s Commodity Inert Ingredients List.
In addition to issues related to COVID-19, we are also:
Additionally, the Scientific & Regulatory Affairs team has productive working relationships with federal and state agencies, including the Environmental Protection Agency (EPA), Consumer Product Safety Commission (CPSC), and California Air Resources Board (CARB). Members are often invited to participate in meetings with senior-level officials from each of these agencies to discuss the industry’s perspective on scientific and regulatory issues. Additionally, Scientific & Regulatory Affairs staff provide technical and stakeholder input to the EPA by serving on advisory committees, including the Science Advisory Committee on Chemicals (SACC) and the Pesticide Program Dialogue Committee (PPDC). We also regularly coordinate with other U.S. and international trade associations to align on scientific and regulatory issues.
In order to help our members expand and enhance their knowledge of important issues, HCPA regularly hosts meetings, workshops, and webinars about priority issues, featuring insight from industry experts.